Bio-Techne Corp’s recent filing unveils that its Director Herr Amy E. unloaded Company’s shares for reported $63705.0 on Jun 09 ’25. In the deal valued at $49.77 per share,1,280 shares were sold. As a result of this transaction, Herr Amy E. now holds 1,976 shares worth roughly $0.12 million.
Then, JOSHUA MOLHO bought 1,280 shares, generating $63,705 in total proceeds.
Before that, Herr Amy E. sold 1,860 shares. Bio-Techne Corp shares valued at $122,691 were divested by the Director at a price of $65.96 per share. As a result of the transaction, Herr Amy E. now holds 1,976 shares, worth roughly $0.12 million.
A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in early July with a ‘”a Buy”‘ rating. Wells Fargo began covering TECH with “an Overweight” recommendation on May 30, 2025. KeyBanc Capital Markets revised its rating on April 09, 2025. It rated TECH as “a Sector weight” which previously was an “an Overweight”.
Price Performance Review of TECH
On Monday, Bio-Techne Corp [NASDAQ:TECH] saw its stock fall -0.39% to $58.55. Over the last five days, the stock has gained 16.47%. Bio-Techne Corp shares have fallen nearly -24.56% since the year began. Nevertheless, the stocks have fallen -18.71% over the past one year. While a 52-week high of $83.62 was reached on 02/05/25, a 52-week low of $46.01 was recorded on 04/21/25.
Levels Of Support And Resistance For TECH Stock
The 24-hour chart illustrates a support level at 57.92, which if violated will result in even more drops to 57.29. On the upside, there is a resistance level at 59.62. A further resistance level may holdings at 60.69.
How much short interest is there in Bio-Techne Corp?
A steep rise in short interest was recorded in Bio-Techne Corp stocks on 2025-07-15, growing by 0.39 million shares to a total of 6.53 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 6.14 million shares. There was a rise of 5.99%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 18, 2025 when Evercore ISI began covering the stock and recommended ‘”an Outperform”‘ rating along with a $75 price target.
